US Stock MarketDetailed Quotes

IOBT IO Biotech

Watchlist
  • 0.890
  • +0.119+15.38%
Close Dec 23 16:00 ET
  • 0.930
  • +0.040+4.53%
Post 19:47 ET
58.61MMarket Cap-0.69P/E (TTM)

IO Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-30.13%-20.81M
7.01%-16.98M
-69.72%-24.93M
-20.10%-71.74M
-81.98%-22.8M
-19.79%-15.99M
-40.36%-18.26M
29.52%-14.69M
-46.95%-59.73M
34.90%-12.53M
Net income from continuing operations
-10.78%-24.02M
2.32%-20.69M
-14.16%-19.46M
-20.47%-86.08M
-30.45%-26.18M
-38.19%-21.68M
-14.51%-21.18M
0.93%-17.04M
-5.27%-71.46M
5.81%-20.07M
Operating gains losses
-576.61%-1.63M
1,000.00%90K
279.07%462K
-154.62%-331K
22.41%-405K
293.10%342K
-103.51%-10K
-1,390.00%-258K
59.25%-130K
-4,250.00%-522K
Depreciation and amortization
5.67%205K
14.44%214K
21.26%211K
40.00%756K
5.79%201K
63.03%194K
1,600.00%187K
-20.91%174K
26,900.00%540K
9,400.00%190K
Deferred tax
----
----
----
--0
----
----
----
----
--87K
----
Change In working capital
36.32%2.95M
57.58%1.76M
-1,502.73%-7.72M
39.84%5.86M
-66.83%2.03M
910.49%2.16M
-70.89%1.12M
110.00%550K
640.21%4.19M
470.14%6.13M
-Change in prepaid assets
352.41%846K
-195.12%-760K
-210.21%-2.08M
-65.75%1.57M
-237.11%-1.31M
-91.71%187K
-68.10%799K
266.23%1.89M
156.59%4.58M
125.08%954K
-Change in payables and accrued expense
10.45%2.32M
475.22%2.67M
-1,190.63%-4.69M
2,514.78%4.9M
-39.98%2.71M
184.72%2.1M
-77.29%464K
91.52%-363K
-102.77%-203K
-8.10%4.51M
-Change in other current assets
-318.18%-48K
135.71%5K
0.00%-792K
90.91%-4K
8.94%780K
0.00%22K
98.19%-14K
-8,700.00%-792K
-76.00%-44K
--716K
-Change in other current liabilities
-15.60%-163K
-17.16%-157K
16.22%-155K
-334.53%-604K
-200.00%-144K
-98.59%-141K
-343.64%-134K
-146.67%-185K
---139K
---48K
Cash from discontinued investing activities
Operating cash flow
-30.13%-20.81M
7.01%-16.98M
-69.72%-24.93M
-20.10%-71.74M
-81.98%-22.8M
-19.79%-15.99M
-40.36%-18.26M
29.52%-14.69M
-46.95%-59.73M
34.90%-12.53M
Investing cash flow
Cash flow from continuing investing activities
58.33%-10K
69.23%-12K
92.57%-11K
53.19%-323K
67.91%-112K
79.66%-24K
63.55%-39K
-27.59%-148K
-350.98%-690K
-132.67%-349K
Net PPE purchase and sale
58.33%-10K
69.23%-12K
92.57%-11K
53.19%-323K
67.91%-112K
79.66%-24K
63.55%-39K
-27.59%-148K
-350.98%-690K
-132.67%-349K
Cash from discontinued investing activities
Investing cash flow
58.33%-10K
69.23%-12K
92.57%-11K
53.19%-323K
67.91%-112K
79.66%-24K
63.55%-39K
-27.59%-148K
-350.98%-690K
-132.67%-349K
Financing cash flow
Cash flow from continuing financing activities
71.86M
-10K
0
0
Net common stock issuance
----
----
----
--75.06M
--0
----
----
----
--0
--0
Net other financing activities
----
----
----
---3.2M
---10K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
--71.86M
---10K
--71.87M
--0
--0
--0
--0
Net cash flow
Beginning cash position
-8.47%101.02M
-8.19%118.25M
0.42%143.46M
-32.55%142.86M
9.46%165.77M
-35.23%110.36M
-31.55%128.8M
-32.55%142.86M
6,120.23%211.8M
232.99%151.44M
Current changes in cash
-137.27%-20.82M
7.14%-16.99M
-68.10%-24.94M
99.67%-200K
-78.00%-22.92M
514.79%55.86M
-39.51%-18.3M
29.21%-14.84M
-128.48%-60.42M
-107.66%-12.88M
Effect of exchange rate changes
156.89%256K
-83.97%-241K
-134.58%-268K
109.42%803K
-85.83%609K
91.80%-450K
97.19%-131K
129.06%775K
-126.77%-8.52M
334.68%4.3M
End cash Position
-51.47%80.45M
-8.47%101.02M
-8.19%118.25M
0.42%143.46M
0.42%143.46M
9.46%165.77M
-35.23%110.36M
-31.55%128.8M
-32.55%142.86M
-32.55%142.86M
Free cash flow
-30.00%-20.82M
7.14%-16.99M
-68.10%-24.94M
-19.27%-72.06M
-77.92%-22.91M
-18.92%-16.01M
-39.51%-18.3M
29.21%-14.84M
-48.09%-60.42M
33.60%-12.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -30.13%-20.81M7.01%-16.98M-69.72%-24.93M-20.10%-71.74M-81.98%-22.8M-19.79%-15.99M-40.36%-18.26M29.52%-14.69M-46.95%-59.73M34.90%-12.53M
Net income from continuing operations -10.78%-24.02M2.32%-20.69M-14.16%-19.46M-20.47%-86.08M-30.45%-26.18M-38.19%-21.68M-14.51%-21.18M0.93%-17.04M-5.27%-71.46M5.81%-20.07M
Operating gains losses -576.61%-1.63M1,000.00%90K279.07%462K-154.62%-331K22.41%-405K293.10%342K-103.51%-10K-1,390.00%-258K59.25%-130K-4,250.00%-522K
Depreciation and amortization 5.67%205K14.44%214K21.26%211K40.00%756K5.79%201K63.03%194K1,600.00%187K-20.91%174K26,900.00%540K9,400.00%190K
Deferred tax --------------0------------------87K----
Change In working capital 36.32%2.95M57.58%1.76M-1,502.73%-7.72M39.84%5.86M-66.83%2.03M910.49%2.16M-70.89%1.12M110.00%550K640.21%4.19M470.14%6.13M
-Change in prepaid assets 352.41%846K-195.12%-760K-210.21%-2.08M-65.75%1.57M-237.11%-1.31M-91.71%187K-68.10%799K266.23%1.89M156.59%4.58M125.08%954K
-Change in payables and accrued expense 10.45%2.32M475.22%2.67M-1,190.63%-4.69M2,514.78%4.9M-39.98%2.71M184.72%2.1M-77.29%464K91.52%-363K-102.77%-203K-8.10%4.51M
-Change in other current assets -318.18%-48K135.71%5K0.00%-792K90.91%-4K8.94%780K0.00%22K98.19%-14K-8,700.00%-792K-76.00%-44K--716K
-Change in other current liabilities -15.60%-163K-17.16%-157K16.22%-155K-334.53%-604K-200.00%-144K-98.59%-141K-343.64%-134K-146.67%-185K---139K---48K
Cash from discontinued investing activities
Operating cash flow -30.13%-20.81M7.01%-16.98M-69.72%-24.93M-20.10%-71.74M-81.98%-22.8M-19.79%-15.99M-40.36%-18.26M29.52%-14.69M-46.95%-59.73M34.90%-12.53M
Investing cash flow
Cash flow from continuing investing activities 58.33%-10K69.23%-12K92.57%-11K53.19%-323K67.91%-112K79.66%-24K63.55%-39K-27.59%-148K-350.98%-690K-132.67%-349K
Net PPE purchase and sale 58.33%-10K69.23%-12K92.57%-11K53.19%-323K67.91%-112K79.66%-24K63.55%-39K-27.59%-148K-350.98%-690K-132.67%-349K
Cash from discontinued investing activities
Investing cash flow 58.33%-10K69.23%-12K92.57%-11K53.19%-323K67.91%-112K79.66%-24K63.55%-39K-27.59%-148K-350.98%-690K-132.67%-349K
Financing cash flow
Cash flow from continuing financing activities 71.86M-10K00
Net common stock issuance --------------75.06M--0--------------0--0
Net other financing activities ---------------3.2M---10K--------------------
Cash from discontinued financing activities
Financing cash flow --0--0--0--71.86M---10K--71.87M--0--0--0--0
Net cash flow
Beginning cash position -8.47%101.02M-8.19%118.25M0.42%143.46M-32.55%142.86M9.46%165.77M-35.23%110.36M-31.55%128.8M-32.55%142.86M6,120.23%211.8M232.99%151.44M
Current changes in cash -137.27%-20.82M7.14%-16.99M-68.10%-24.94M99.67%-200K-78.00%-22.92M514.79%55.86M-39.51%-18.3M29.21%-14.84M-128.48%-60.42M-107.66%-12.88M
Effect of exchange rate changes 156.89%256K-83.97%-241K-134.58%-268K109.42%803K-85.83%609K91.80%-450K97.19%-131K129.06%775K-126.77%-8.52M334.68%4.3M
End cash Position -51.47%80.45M-8.47%101.02M-8.19%118.25M0.42%143.46M0.42%143.46M9.46%165.77M-35.23%110.36M-31.55%128.8M-32.55%142.86M-32.55%142.86M
Free cash flow -30.00%-20.82M7.14%-16.99M-68.10%-24.94M-19.27%-72.06M-77.92%-22.91M-18.92%-16.01M-39.51%-18.3M29.21%-14.84M-48.09%-60.42M33.60%-12.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data